Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trialIvan Fan-Ngai Hung, Kwok-Yung Yuen, Kwok-Cheung Lung et al.|The Lancet|2020Cited by 1.6k
Emerging SARS-CoV-2 variants expand species tropism to murinesHuiping Shuai, Hin Chu, Jasper Fuk‐Woo Chan et al.|EBioMedicine|2021Cited by 192
Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipientsLu Lu, Kelvin Kai‐Wang To, Bobo Wing-Yee Mok et al.|medRxiv|2021Cited by 131
SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case seriesIvan Fan-Ngai Hung, Kwok-Yung Yuen, Vincent Chi‐Chung Cheng et al.|The Lancet Infectious Diseases|2020Cited by 131
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or VaccinationLin‐Lei Chen, Kelvin Kai‐Wang To, Lu Lu et al.|Clinical Infectious Diseases|2021Cited by 51